succinylacetone has been researched along with Nervous System Disorders in 2 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wyss, PA | 1 |
| Boynton, S | 1 |
| Chu, J | 1 |
| Roth, KS | 1 |
| Raff, RF | 1 |
| Storb, R | 1 |
| Graham, T | 1 |
| Fidler, JM | 1 |
| Sale, GE | 1 |
| Johnston, B | 1 |
| Deeg, HJ | 1 |
| Pepe, M | 1 |
| Schuening, F | 1 |
| Appelbaum, FR | 1 |
2 other studies available for succinylacetone and Nervous System Disorders
| Article | Year |
|---|---|
Tissue distribution of succinylacetone in the rat in vivo: a possible basis for neurotoxicity in hereditary infantile tyrosinemia.
Topics: Animals; Animals, Newborn; Brain; Heme; Heptanoates; Kidney; Liver; Male; Nervous System Diseases; P | 1993 |
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
Topics: Animals; Bone Marrow Transplantation; Dogs; Female; Graft Rejection; Graft vs Host Disease; Haploidy | 1992 |